Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Structural and calorimetric studies demonstrate that the hepatocyte nuclear factor 1β (HNF1β) transcription factor is imported into the nucleus via a monopartite NLS sequence.
Wiedmann MM
,
Aibara S
,
Spring DR
,
Stewart M
,
Brenton JD
.
???displayArticle.abstract???
The transcription factor hepatocyte nuclear factor 1β (HNF1β) is ubiquitously overexpressed in ovarian clear cell carcinoma (CCC) and is a potential therapeutic target. To explore potential approaches that block HNF1β transcription we have identified and characterised extensively the nuclear localisation signal (NLS) for HNF1β and its interactions with the nuclear protein import receptor, Importin-α. Pull-down assays demonstrated that the DNA binding domain of HNF1β interacted with a spectrum of Importin-α isoforms and deletion constructs tagged with eGFP confirmed that the HNF1β (229)KKMRRNR(235) sequence was essential for nuclear localisation. We further characterised the interaction between the NLS and Importin-α using complementary biophysical techniques and have determined the 2.4Å resolution crystal structure of the HNF1β NLS peptide bound to Importin-α. The functional, biochemical, and structural characterisation of the nuclear localisation signal present on HNF1β and its interaction with the nuclear import protein Importin-α provide the basis for the development of compounds targeting transcription factor HNF1β via its nuclear import pathway.
Fig. 1. (A) HNF1β protein expression levels in CCC cell lines OVISE, JHOC5, JHOC7, JHOC9, SKOV3 and a negative control HGSOC cell line, PEO1; (B) Data is the mean (n = 3, three biological replicates) and SEM. Expression levels were normalised to the housekeeping protein GAPDH. The expression levels observed with JHOC5 (P < 0.005, âââ) and OVISE (P < 0.05, â) cells were significantly higher than PEO1.
Fig. 2. eGFP imaging of PEO1 transduced lines with (a) eGFP-HNF1β (Lv103) showed primarily nuclear localisation of the GFP signal, whereas cells transduced with eGFP (Lv105) alone (b) showed both nuclear and cytoplasmic localisation. In cells transduced with eGFP-HNF1β (Lv103) in which the seven-residue NLS had been deleted (c, Mutant 8) the eGFP signal was mislocalized to the cytoplasm. The scale bar represents 80 μm. Images were taken on a Leica tandem confocal microscope using 20×, 40× and 60× objectives.
Fig. 3. (A) Stable complex formation between ÎIBB mouse Importin-α1 (50 kDa) and HNF1β (27 kDa) during size exclusion chromatography. Fractions were analysed by Coomassie stained SDS-PAGE (â marks the peak for the complex); (B) GST pull-down with liberated HNF1β showing pull-downs using different ÎIBB mouse Importin-α isoforms (red â).
Fig. 4. (A) ITC titration for the binding of the HNF1β NLS peptide to ÎIBB mImportin-α1. Fitting the data (with Ï2/DoF = 2.9 Ã 104) gave a Kd of 13.6 ± 1.5 nM for 0.94 ± 0.13 sites, ÎH = â7.2 ± 1.6 kcal/mol, ÎS = â1.7 cal/mol/deg. (B) In pull-down assays, GST-HNF1β bound only the E mutant of ÎIBB Xenopus Importin-α1 (that impairs NLS binding at the minor site) Mr 50 kD, but not the D mutant (that impairs binding at the major site) or ED double mutant (see Giesecke and Stewart, 2010).
Fig. 5. (A) Overview of the 2.4 à crystal structure of the ÎIBB mouse Importin-α1:HNF1βNLS complex. Two copies of the NLS peptide were observed where one was bound in the major site (blue) and another in the minor site (yellow). Each ARM repeat of mouse Importin-α1 has been labelled with alternating colours. (B) Final 2Fo-Fc electron density map around NLS peptide in major and minor binding sites on mouse Importin-α1 contoured at 1Ï.
Fig. 6. Schematic illustration of the interactions of the HNF1βNLS peptide in the major (A) and minor (B) sites on ÎIBB mouse Importin-α1.
Adams,
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
2010, Pubmed
Adams,
PHENIX: a comprehensive Python-based system for macromolecular structure solution.
2010,
Pubmed
Anglesio,
Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010.
2011,
Pubmed
Bach,
More potent transcriptional activators or a transdominant inhibitor of the HNF1 homeoprotein family are generated by alternative RNA processing.
1993,
Pubmed
Bach,
Two members of an HNF1 homeoprotein family are expressed in human liver.
1991,
Pubmed
Bitler,
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers.
2015,
Pubmed
Bohn,
Distinct molecular and morphogenetic properties of mutations in the human HNF1beta gene that lead to defective kidney development.
2003,
Pubmed
,
Xenbase
Chang,
Distinctive conformation of minor site-specific nuclear localization signals bound to importin-α.
2013,
Pubmed
Chen,
MolProbity: all-atom structure validation for macromolecular crystallography.
2010,
Pubmed
Cribbs,
Simplified production and concentration of lentiviral vectors to achieve high transduction in primary human T cells.
2013,
Pubmed
Cutress,
Structural basis for the nuclear import of the human androgen receptor.
2008,
Pubmed
Emsley,
Features and development of Coot.
2010,
Pubmed
Evans,
How good are my data and what is the resolution?
2013,
Pubmed
Fontes,
Structural basis of recognition of monopartite and bipartite nuclear localization sequences by mammalian importin-alpha.
2000,
Pubmed
Giesecke,
Novel binding of the mitotic regulator TPX2 (target protein for Xenopus kinesin-like protein 2) to importin-alpha.
2010,
Pubmed
,
Xenbase
Gounaris,
Ovarian clear cell carcinoma--bad endometriosis or bad endometrium?
2011,
Pubmed
Hodel,
Nuclear localization signal receptor affinity correlates with in vivo localization in Saccharomyces cerevisiae.
2006,
Pubmed
Holvey,
Selective Targeting of the TPX2 Site of Importin-α Using Fragment-Based Ligand Design.
2015,
Pubmed
Jones,
Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma.
2010,
Pubmed
Kabsch,
XDS.
2010,
Pubmed
Kajihara,
Clear cell carcinoma of the ovary: potential pathogenic mechanisms (Review).
2010,
Pubmed
Kato,
Hypomethylation of hepatocyte nuclear factor-1beta (HNF-1beta) CpG island in clear cell carcinoma of the ovary.
2008,
Pubmed
Kato,
Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma.
2007,
Pubmed
Kato,
Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary.
2006,
Pubmed
Kobayashi,
The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary.
2009,
Pubmed
Kobe,
Autoinhibition by an internal nuclear localization signal revealed by the crystal structure of mammalian importin alpha.
1999,
Pubmed
Kuo,
Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma.
2009,
Pubmed
Kutner,
Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors.
2009,
Pubmed
Landen,
Early events in the pathogenesis of epithelial ovarian cancer.
2008,
Pubmed
Lange,
Classical nuclear localization signals: definition, function, and interaction with importin alpha.
2007,
Pubmed
Lin,
Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence.
1995,
Pubmed
Liu,
Regulation of HSulf-1 expression by variant hepatic nuclear factor 1 in ovarian cancer.
2009,
Pubmed
Lu,
Structural basis of disease-causing mutations in hepatocyte nuclear factor 1beta.
2007,
Pubmed
Lu,
Crystallization of hepatocyte nuclear factor 1beta in complex with DNA.
2006,
Pubmed
Marfori,
Molecular basis for specificity of nuclear import and prediction of nuclear localization.
2011,
Pubmed
Marfori,
Structural basis of high-affinity nuclear localization signal interactions with importin-α.
2012,
Pubmed
Nakada,
Structure of importin-α bound to a non-classical nuclear localization signal of the influenza A virus nucleoprotein.
2015,
Pubmed
Rey-Campos,
vHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1.
1991,
Pubmed
Rosenfeld,
POU-domain transcription factors: pou-er-ful developmental regulators.
1991,
Pubmed
Ryan,
POU domain family values: flexibility, partnerships, and developmental codes.
1997,
Pubmed
Shen,
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.
2013,
Pubmed
Stelma,
Targeting nuclear transporters in cancer: Diagnostic, prognostic and therapeutic potential.
2016,
Pubmed
Stewart,
Molecular mechanism of the nuclear protein import cycle.
2007,
Pubmed
Tan,
New perspectives on molecular targeted therapy in ovarian clear cell carcinoma.
2013,
Pubmed
Tan,
Ovarian clear cell adenocarcinoma: a continuing enigma.
2007,
Pubmed
Torgerson,
Regulation of NF-kappa B, AP-1, NFAT, and STAT1 nuclear import in T lymphocytes by noninvasive delivery of peptide carrying the nuclear localization sequence of NF-kappa B p50.
1998,
Pubmed
Tsuchiya,
Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma.
2003,
Pubmed
Wiegand,
ARID1A mutations in endometriosis-associated ovarian carcinomas.
2010,
Pubmed
Wu,
The HNF1beta transcription factor has several domains involved in nephrogenesis and partially rescues Pax8/lim1-induced kidney malformations.
2004,
Pubmed
,
Xenbase
Yamaguchi,
Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.
2010,
Pubmed
Yoshida,
Theoretical model of treatment strategies for clear cell carcinoma of the ovary: focus on perspectives.
2009,
Pubmed
